Lunaphore launches Comet antibody instrument in U.K.

By The Science Advisory Board staff writers

May 9, 2022 -- Lunaphore installed its Comet Primary Antibodies (PA) instrument at Propath U.K., the first contract research organization (CRO) in Europe to offer the service.

Comet PA is an automated sequential immunofluorescence (seqIF) instrument that performs hyperplex staining and imaging. It allows multiplex analysis of up to 40 different spatial markers per tissue slide without human intervention, according to Lunaphore.

The instrument can aid understanding in the areas of immuno-oncology, neuroscience, and infectious diseases, the firm added.

Copyright © 2022

Glasgow International Health Festival
August 24-27
Glasgow, Glasgow City United Kingdom
Pharma Competitive Intelligence Conference and Exhibition
September 21-22
Newark, New Jersey United States
BioProcess International (BPI) Conference
September 27-30
Boston, Massachusetts United States
Laboratory Products Association Annual Meeting
October 1-4
Scottsdale, Arizona United States
Science Advisory Board on LinkedIn
Science Advisory Board on Facebook
Science Advisory Board on Twitter